Session Details Page | International Bar Association

9th Annual IBA World Life Sciences Conference

31 May - 2 Jun 2023

Session information

Plenary session three - M&A panel on current trends in the HCLS industry

Thursday 1 June (1600 - 1700)

Description

The M&A panel will focus on recent worldwide M&A activity in the life science sector, and market dynamics that are impacting levels of M&A activity. The panel will consider various types of deals as well as alternatives to M&A such as licensing and collaboration deals between biotechs and big pharma. Considerations such as the state of capital markets and regulatory developments will also be reviewed.

Session / Workshop Chair(s)

Bill Whelan	Mintz, Boston, Massachusetts, USA

Speakers

Lorenza Ferrari-Hofer	Schellenberg Wittmer, Zürich, Switzerland
Pamela F Forrest	Covington & Burling LLP, Washington, District of Columbia, USA
Murphy Gallagher	SVB Securities, Washington, District of Columbia, USA
Jabali Wells	Blackpoll Capital Partners LLC, Washington, District of Columbia, USA
Feng Zhou	JunHe LLP, Shanghai, China; Membership Officer, Healthcare and Life Sciences Law Committee

Session presentations

Plenary_Session_Three_Gallagher_Presentation

International Bar Association is incorporated as a Not-for-Profit Corporation under the laws of the State of New York in the United States of America and is registered with the Department of State of the State of New York with registration number 071114000655 - and the liability of its members is limited. Its registered address in New York is c/o Capitol Services Inc, 1218 Central Avenue, Suite 100, Albany, New York 12205.

The London office of International Bar Association is registered in England and Wales as a branch with registration number FC028342.